STAT

Health insurers are using more AI but a lack of transparency makes it difficult to understand the impact on patients https://trib.al/VHTAtcF

How do obesity biotechs compete against Novo Nordisk and Eli Lilly and Company? Why does gene therapy pioneer Jim Wilson think there’s “irrational pessimism” in the field? And why isn’t Immunovant advancing the drug it just reported positive data on? Thank you to The Readout LOUD podcast sponsor, Invest Puerto Rico. The end of this week's episode features a STAT Brand Studio conversation with Robert Salcedo, CEO of OcyonBio, who discusses Puerto Rico’s leadership as a biopharma hub. Listen: https://lnkd.in/e_UST8as

There are certain leaders who quietly make complex organizations operate well including in the toughest of times — leaders like Peter Marks, director of the Center for Biologics Evaluation and Research (CBER), who resigned Friday https://trib.al/xsggMH1

With MAHA as an accelerant, states are attempting to exert influence over national policy and corporate practices that affect health https://trib.al/zfIzDub

Toronto-based Altis Labs uses AI tool to review lung cancer CT scans to predict future patient survival. https://trib.al/ytsVXXS

NEW: Some FDA employees who were previously working in pantries and conference rooms can work from home for now, according to an email reviewed by STAT. https://lnkd.in/enszMy5d

Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump. https://trib.al/nz8JAMx

HHS is set to cut 10,000 jobs and consolidate divisions — have you been affected? We would like to hear from you. https://trib.al/N5cFVna

The FDA bends its new return to office policy, acknowledging that pantries and conference rooms may not be acceptable workstations. https://trib.al/EnlCJsd

Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business outside of Colorado. https://trib.al/KZxprL9